These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11745341)

  • 1. IL-2 down-regulates the expression of TCR and TCR-associated surface molecules on CD8(+) T cells.
    Kambayashi T; Assarsson E; Chambers BJ; Ljunggren HG
    Eur J Immunol; 2001 Nov; 31(11):3248-54. PubMed ID: 11745341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
    J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 alpha coreceptor to improve TCR gene transfer to treat melanoma: down-regulation of tumor-specific production of IL-4, IL-5, and IL-10.
    Willemsen RA; Sebestyén Z; Ronteltap C; Berrevoets C; Drexhage J; Debets R
    J Immunol; 2006 Jul; 177(2):991-8. PubMed ID: 16818755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-15 promotes survival but not effector function differentiation of CD8+ TCRalphabeta+ intestinal intraepithelial lymphocytes.
    Lai YG; Gelfanov V; Gelfanova V; Kulik L; Chu CL; Jeng SW; Liao NS
    J Immunol; 1999 Dec; 163(11):5843-50. PubMed ID: 10570268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
    Niedbala W; Wei X; Liew FY
    Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles.
    Croft M; Carter L; Swain SL; Dutton RW
    J Exp Med; 1994 Nov; 180(5):1715-28. PubMed ID: 7525836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune deviation of 2C transgenic intraepithelial lymphocytes in antigen-bearing hosts.
    Guehler SR; Bluestone JA; Barrett TA
    J Exp Med; 1996 Aug; 184(2):493-503. PubMed ID: 8760803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
    Curtsinger JM; Lins DC; Mescher MF
    J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I and TCR avidity control the CD8 T cell response to IL-15/IL-15Rα complex.
    Stoklasek TA; Colpitts SL; Smilowitz HM; Lefrançois L
    J Immunol; 2010 Dec; 185(11):6857-65. PubMed ID: 21041729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28, IL-2-independent costimulatory pathways for CD8 T lymphocyte activation.
    Sepulveda H; Cerwenka A; Morgan T; Dutton RW
    J Immunol; 1999 Aug; 163(3):1133-42. PubMed ID: 10415007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.
    Mannon RB; Kotzin BL; Nataraj C; Ferri K; Roper E; Kurlander RJ; Coffman TM
    J Clin Invest; 1998 Jun; 101(11):2517-27. PubMed ID: 9616223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of thymocyte proliferation by alpha beta TcR+ CD3+ CD4- CD8- cloned natural suppressor (NS) cells.
    Van Vlasselaer P; Fischer M; Strober S; Zlotnik A
    Cell Immunol; 1991 Aug; 136(1):1-15. PubMed ID: 1829396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
    van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of CD8beta-mediated T cell response enhancement: interaction with MHC class I/beta2-microglobulin and functional coupling to TCR/CD3.
    Wheeler CJ; Chen JY; Potter TA; Parnes JR
    J Immunol; 1998 May; 160(9):4199-207. PubMed ID: 9574520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2-activated murine cell lines with macrophage- and B-lymphoblast-lytic activity.
    Suzuki H; Ikemoto M; Yokoyama A; Kamitani T; Yamashita N; Maruyama M; Yano S
    Cell Immunol; 1991 Jan; 132(1):127-39. PubMed ID: 1829651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
    Rapoport MJ; Jaramillo A; Zipris D; Lazarus AH; Serreze DV; Leiter EH; Cyopick P; Danska JS; Delovitch TL
    J Exp Med; 1993 Jul; 178(1):87-99. PubMed ID: 8315397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the phenotype and function of CD8(+), alpha / beta(+) NKT cells from tumor-bearing mice that show a natural killer cell activity and lyse multiple tumor targets.
    Stremmel C; Exley M; Balk S; Hohenberger W; Kuchroo VK
    Eur J Immunol; 2001 Sep; 31(9):2818-28. PubMed ID: 11536181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.